Atractylon, at an appropriate concentration, can significantly inhibit the proliferation and promote the apoptosis of intestinal cancer cells via suppressing the PI3K/AKT/mTOR signaling pathway, which may be a potential candidate for the treatment of colorectal cancer and other related diseases. The gene discussed is AKT1; the disease is colorectal cancer.